Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia’s Concentriq Selected for Joint Pathology Center

Proscia
By Author Proscia | October 21, 2020

The Joint Pathology Center (JPC), the premiere pathology reference center for the United States government, has selected the Concentriq platform from Philadelphia-based Proscia for a complete transformation of its pathology practice. At the center of this modernization effort, JPC will digitize its tissue archive, the world’s largest repository of human pathology specimens, to capitalize on this invaluable source of medical data. The digital repository will provide increased access to data for driving medical advances related to infectious diseases and cancer as well as accelerate the development of computational pathology applications establishing diagnosis, prognosis, and personalized therapies for patients.

Our website uses cookies. By using this site, you agree to its use of cookies.